8-K: Planet 13 Holdings Announces Public Offering and Acquisition of VidaCann

Planet 13 Holdings has commenced an underwritten public offering of units and is providing additional disclosures related to its acquisition of VidaCann and the sale of its Florida license.

Summary

• Planet 13 Holdings has initiated an underwritten public offering of units, each consisting of one share of common stock and a warrant to purchase one share of common stock.
• The company intends to use the proceeds for working capital, general corporate purposes, potential acquisitions of retail cannabis licenses in Nevada, expansion in Florida and Illinois, and other capital improvements.
• Planet 13 is also providing additional information regarding its pending acquisition of VidaCann, LLC and the related sale of its Florida Medical Marijuana Treatment Center license.
• The acquisition of VidaCann and the sale of the Florida license are expected to close in the first or early second quarter of 2024, pending regulatory approvals.
• The company has filed historical financial statements of VidaCann and pro forma financial information, including VidaCann, as part of this announcement.
• The pro forma financials include a combined balance sheet as of September 30, 2023, and statements of operations for the nine months ended September 30, 2023, and the year ended December 31, 2022.
• The pro forma financials reflect the acquisition of VidaCann and the disposition of Planet 13 Florida Inc.
• The total consideration for the VidaCann acquisition is valued at approximately $77.3 million, including shares, cash, and promissory notes.
• The company estimates goodwill of $55.4 million as part of the acquisition.
• The company will issue 78,461,538 shares of common stock to VidaCann members and advisors as part of the acquisition.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While the company is pursuing growth through acquisitions and capital raising, the significant pro forma losses and the risks associated with the transactions temper the positive outlook. The sentiment is neutral to slightly negative.

Positives

• The public offering provides Planet 13 with capital for growth and expansion.
• The acquisition of VidaCann expands Planet 13's operations in Florida.
• The sale of the Florida license provides $9 million in cash.
• The pro forma financials provide transparency into the combined company's financial position.
• The company is actively pursuing growth opportunities in multiple states.

Negatives

• The company reported a pro forma net loss of $66.4 million for the nine months ended September 30, 2023.
• The company is incurring significant transaction costs related to the acquisition and offering.
• The acquisition is subject to regulatory approvals and customary closing conditions.
• The company is issuing a significant number of shares as part of the acquisition, which may dilute existing shareholders.
• The company is taking on $5 million in promissory notes as part of the acquisition.

Risks

• The public offering is subject to market conditions and may not be completed.
• The acquisition of VidaCann and the sale of the Florida license are subject to regulatory approvals and may not close.
• The company's operations are subject to the risks of the cannabis industry, including regulatory changes and competition.
• The company's financial performance may be impacted by the integration of VidaCann.
• The company's future performance is subject to the risks and uncertainties identified in its filings with the SEC and Canadian regulators.

Future Outlook

The company expects the acquisition of VidaCann and the sale of the Florida license to close in the first or early second quarter of 2024, subject to customary closing conditions and regulatory approvals. The company intends to use the proceeds from the public offering for working capital, general corporate purposes, potential acquisitions, and expansion.

Management Comments

• The company intends to use the net proceeds from the Offering for working capital and general corporate purposes, which may include, but are not limited to, the acquisition of additional retail cannabis licenses in the state of Nevada, the expansion of its retail presence in Florida and Illinois and other capital improvements.
• Planet 13's mission is to build a recognizable global brand known for world-class dispensary operations and innovative cannabis products.

Industry Context

This announcement reflects the ongoing consolidation and expansion within the cannabis industry, with companies seeking to increase their market share through acquisitions and strategic growth initiatives. The public offering is a common method for cannabis companies to raise capital for expansion. The acquisition of VidaCann is a move to increase market share in Florida, a key market for cannabis.

Comparison to Industry Standards

• The pro forma combined revenue of approximately $141 million for 2022 is comparable to other mid-sized multi-state cannabis operators.
• The company's focus on large-scale retail operations, such as its Las Vegas dispensary, is a differentiating factor compared to smaller operators.
• The acquisition of VidaCann is similar to other acquisitions in the cannabis industry, where companies are seeking to expand their geographic footprint and market share.
• The company's expansion into Illinois and Florida is in line with industry trends of targeting high-growth markets.
• The company's reliance on capital markets for funding is typical of the cannabis industry, where access to traditional financing is limited.

Related Party Transactions

• VidaCann has related party transactions including leases and purchases with investors.

Stakeholder Impact

• Shareholders will be impacted by the potential dilution from the issuance of new shares.
• Employees of VidaCann will be integrated into Planet 13.
• Customers of VidaCann will become customers of Planet 13.
• Suppliers of VidaCann will become suppliers of Planet 13.
• Creditors of VidaCann will be impacted by the acquisition.

Next Steps

• The company will file a preliminary prospectus supplement with the SEC.
• The company will seek regulatory approvals for the acquisition of VidaCann and the sale of the Florida license.
• The company will complete the public offering of units.
• The company will integrate VidaCann into its operations.
• The company will continue to pursue growth opportunities in Nevada, Florida, and Illinois.

Key Dates

Keywords

public offering, cannabis, acquisition, VidaCann, Planet 13, Florida, dispensary, financial statements, pro forma, warrants, shares, MMTC license